Symposium 1: Japanese Society of Allergology: Update on Atopic Dermatitis
1-1SSS: Altered Skin Barrier Functions
1-1SSS: Altered Skin Barrier Functions
Symposium 1: Harvard University: Adverse Drug Reactions and Managements
1-1UTP: Chemo-Therapeutic Agents
1-1UTP: Chemo-Therapeutic Agents
Symposium 1: American Thoracic Society (ATS) Session: Emerging Issues in COPD
1-2CPS: The Microbiome in Asthma and COPD
1-2CPS: The Microbiome in Asthma and COPD
Company Sponsored Symposium 1: Sanofi-Aventis: Controlling Allergic Rhinitis
1-2CSS: Co-morbidities in Children with Allergic Rhinitis
1-2CSS: Co-morbidities in Children with Allergic Rhinitis
New Horizons Session 1: Specific Immunotherapy (SIT): History, Mechanisms and Future - This session is co-sponsored by ALK-Abello & MSD
1-2NH: Mechanisms of Sub-Cutaneous Immunotherapy (SCIT)
1-2NH: Mechanisms of Sub-Cutaneous Immunotherapy (SCIT)
Plenary Session 1: Asthma: From Genetics to Treatment
1-2PS: Subphenotyping Asthma to Uncover Novel Genes
1-2PS: Subphenotyping Asthma to Uncover Novel Genes
Symposium 1: Japanese Society of Allergology: Update on Atopic Dermatitis
1-2SSS: Role of Dendritic Cells
1-2SSS: Role of Dendritic Cells
Symposium 1: Harvard University: Adverse Drug Reactions and Managements
1-2UTP: Monoclonal Antibodies
1-2UTP: Monoclonal Antibodies
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-3AH: Eosiniphilic Esophagitis
1-3AH: Eosiniphilic Esophagitis
Company Sponsored Symposium 1: Sanofi-Aventis: Controlling Allergic Rhinitis
1-3CSS: Allergic Rhinitis: Evidence Based Medicine
1-3CSS: Allergic Rhinitis: Evidence Based Medicine
New Horizons Session 1: Specific Immunotherapy (SIT): History, Mechanisms and Future - This session is co-sponsored by ALK-Abello & MSD
1-3NH: Mechanisms of Sub-Lingual Immunotherapy (SLIT)
1-3NH: Mechanisms of Sub-Lingual Immunotherapy (SLIT)
Plenary Session 1: Asthma: From Genetics to Treatment
1-3PS: Personalized Medicine – Is There a Future?
1-3PS: Personalized Medicine – Is There a Future?
Symposium 1: Japanese Society of Allergology: Update on Atopic Dermatitis
1-3SSS: The Role of Food and Egg Allergy
1-3SSS: The Role of Food and Egg Allergy
Workshop 1: Evidence Based Recommendations for Clinical Practice - WAO Special Committee on Evidence Based Medicine
1-3WS: DRACMA in Clinical Practice
1-3WS: DRACMA in Clinical Practice
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-4AH: Guideline-Driven Care
1-4AH: Guideline-Driven Care
New Horizons Session 1: Specific Immunotherapy (SIT): Which Patients for SIT and Anti-IgE? - This session is co-sponsored by ALK-Abello & MSD
1-5NH: For SCIT?
1-5NH: For SCIT?
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-6AH: New Paradigms
1-6AH: New Paradigms
New Horizons Session 1: Specific Immunotherapy (SIT): Which Patients for SIT and Anti-IgE? - This session is co-sponsored by ALK-Abello & MSD
1-6NH: For SLIT?
1-6NH: For SLIT?
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-7AH: Unrecognized Co-morbidity
1-7AH: Unrecognized Co-morbidity
New Horizons Session 1: Specific Immunotherapy (SIT): Which Patients for SIT and Anti-IgE? - This session is co-sponsored by ALK-Abello & MSD
1-7NH: For Anti-IgE?
1-7NH: For Anti-IgE?
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-8AH: Exacerbations
1-8AH: Exacerbations
Allied Health 1: 1st WAO Allied Health Session - Asthma: Diagnosis, Management and Education
1-9AH: Asthma Care: Education and Adherence
1-9AH: Asthma Care: Education and Adherence
New Horizons Session 1: Specific Immunotherapy (SIT): Effectiveness of SIT - This session is co-sponsored by ALK-Abello & MSD
1-9NH: SLIT
1-9NH: SLIT
New Horizons Session 1: Specific Immunotherapy (SIT): Effectiveness of SIT - This session is co-sponsored by ALK-Abello & MSD
1-10NH: SIT and Children
1-10NH: SIT and Children
New Horizons Session 1: Specific Immunotherapy (SIT): Practical Considerations for SIT - This session is co-sponsored by ALK-Abello & MSD
1-12NH: When Should SIT be Started and Why?
1-12NH: When Should SIT be Started and Why?
New Horizons Session 1: Specific Immunotherapy (SIT): Practical Considerations for SIT - This session is co-sponsored by ALK-Abello & MSD
1-13NH: Adverse Effects
1-13NH: Adverse Effects
Allied Health 2: 1st WAO Allied Health Session - Allergic Disorders: Snapshots of a Worldly View
2-1AH: Drug Reactions
2-1AH: Drug Reactions
Breakfast Symposium 2: Clinical Process to Properly Prescribe Immunotherapy
2-1BS: Clinical Process to Properly Prescribe Immunotherapy
2-1BS: Clinical Process to Properly Prescribe Immunotherapy
Company Sponsored Symposium 2: MSD: Uncontrolled Asthma: Burden, Patient Perceptions and Clinical Implications
2-1CSS: Uncontrolled Asthma and Its Burden
2-1CSS: Uncontrolled Asthma and Its Burden
New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis
2-1NH: Allergic Skin Disease: Immunologic Consequences of Playing Host to Pathogenic Microbes
2-1NH: Allergic Skin Disease: Immunologic Consequences of Playing Host to Pathogenic Microbes
Symposium 2: American Academy of Allergy, Asthma and Immunology: Eosinophilic Gastrointestinal (GI) Diseases
2-1SSS: Biology of Eosinophils
2-1SSS: Biology of Eosinophils
Symposium 2: 2012 WAO International Scientific Conference: Superantigens and Severe Airway Disease
2-1SY: New Insights Into Immunologic Mechanisms
2-1SY: New Insights Into Immunologic Mechanisms
Breakfast Symposium 2: Clinical Process to Properly Prescribe Immunotherapy
2-2BS: Clinical Process to Properly Prescribe Immunotherapy
2-2BS: Clinical Process to Properly Prescribe Immunotherapy
Symposium 2: National Institute of Allergy and Infectious Disease (NIAID): Immunological Features of Immunotherapy
2-2CPS: How the Immune System Generates Tolerance
2-2CPS: How the Immune System Generates Tolerance
New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis
2-2NH: Itch: The Primary “Lesion” in Eczema
2-2NH: Itch: The Primary “Lesion” in Eczema
Plenary Session 2: Mastocytosis and Mast Cell Activation Syndromes
2-2PS: Mast Cell Activation Syndromes
2-2PS: Mast Cell Activation Syndromes
Symposium 2: American Academy of Allergy, Asthma and Immunology: Eosinophilic Gastrointestinal (GI) Diseases
2-2SSS: Pathogenesis
2-2SSS: Pathogenesis
Symposium 2: 2012 WAO International Scientific Conference: Superantigens and Severe Airway Disease
2-2SY: Upper Airway
2-2SY: Upper Airway
Symposium 2: Wake Forest University: Translational Medicine and Personalized Asthma Management
2-2UTP: Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management
2-2UTP: Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management
Symposium 2: National Institute of Allergy and Infectious Disease (NIAID): Immunological Features of Immunotherapy
2-3CPS: How Immunology Informs the Design of Immunotherapeutics
2-3CPS: How Immunology Informs the Design of Immunotherapeutics
New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis
2-3NH: Urticaria and Angioedema
2-3NH: Urticaria and Angioedema
Plenary Session 2: Mastocytosis and Mast Cell Activation Syndromes
2-3PS: Anaphylaxis in Mastocytosis and Hymenoptera Allergy
2-3PS: Anaphylaxis in Mastocytosis and Hymenoptera Allergy
Symposium 2: American Academy of Allergy, Asthma and Immunology: Eosinophilic Gastrointestinal (GI) Diseases
2-3SSS: Diagnosis and Management
2-3SSS: Diagnosis and Management
Symposium 2: 2012 WAO International Scientific Conference: Superantigens and Severe Airway Disease
2-3SY: Lower Airway
2-3SY: Lower Airway
Symposium 2: Wake Forest University: Translational Medicine and Personalized Asthma Management
2-3UTP: Understanding Therapeutic Heterogeneity and Responsiveness in Asthma: Future Trends
2-3UTP: Understanding Therapeutic Heterogeneity and Responsiveness in Asthma: Future Trends
Workshop 2: Adverse Reactions to Non-Steroid Anti-Inflammatory Drugs (NSAIDS)
2-3WS: Desensitization
2-3WS: Desensitization
New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis
2-4NH: Cutaneous Vasculitis
2-4NH: Cutaneous Vasculitis
Symposium 2: Wake Forest University: Translational Medicine and Personalized Asthma Management
2-4UTP: Biologic Asthma Therapies and Individualized Medicine
2-4UTP: Biologic Asthma Therapies and Individualized Medicine
Allied Health 2: 1st WAO Allied Health Session - Allergic Disorders: Snapshots of a Worldly View
2-7AH: Food Allergy
2-7AH: Food Allergy
New Horizons Session 2: Skin Diseases: Session 2 - This session is co-sponsored by Novartis
2-7NH: Contact Dermatitis
2-7NH: Contact Dermatitis
Allied Health 2: 1st WAO Allied Health Session - Allergic Disorders: Snapshots of a Worldly View
2-8AH: Asthma Treatment
2-8AH: Asthma Treatment
New Horizons Session 2: Skin Diseases: Session 2 - This session is co-sponsored by Novartis
2-8NH: Anti-IgE Therapy in Allergic Skin Diseases
2-8NH: Anti-IgE Therapy in Allergic Skin Diseases
Allied Health 2: 1st WAO Allied Health Session - Allergic Disorders: Snapshots of a Worldly View
2-9AH: Conclusions
2-9AH: Conclusions
Company Sponsored Symposium 3: Nestle Nutrition Institute: Dietary Prevention and Management of Allergies in Childhood – An Outlook into the Future
3-1CSS: Oral Tolerance Induction: Are we any Closer to a Cure for Food Allergy?
3-1CSS: Oral Tolerance Induction: Are we any Closer to a Cure for Food Allergy?
New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 1
3-1NH: Unique Immunotherapy Approaches
3-1NH: Unique Immunotherapy Approaches
Plenary Session 3: Novel Cytokines in Allergic Diseases
3-1PS: Asthma Phenotypes Shaped by Innate and Adaptive Immunity
3-1PS: Asthma Phenotypes Shaped by Innate and Adaptive Immunity
Symposium 3: Latin American Society of Allergy, Asthma and Immunology: Hot Topics in Latin America
3-1SSS: Air Pollution and Respiratory Disease
3-1SSS: Air Pollution and Respiratory Disease
Symposium 3: Genetic Susceptibility to Airway Diseases
3-1SY: Limitation of Genetic Variants in Asthma Genetics and Advance of Epigenetics
3-1SY: Limitation of Genetic Variants in Asthma Genetics and Advance of Epigenetics
Symposium 3: Henry Ford Hospital, Georgia Health Sciences University, the University of California San Francisco and The University of Michigan: Allergy Prevention: Do Cats and Dogs Feed Infants Microbes?
3-1UTP: The Link Between Pets and Reduced Risk of Allergic Disease
3-1UTP: The Link Between Pets and Reduced Risk of Allergic Disease
Workshop 3: Update on Vaccinations for the Allergist and Immunologist
3-1WS: Pediatric Considerations
3-1WS: Pediatric Considerations
Breakfast Symposium 3: Neonatal Infant Interventions to Prevent Asthma and Allergic Disease
3-2BS: Neonatal Infant Interventions to Prevent Asthma and Allergic Disease
3-2BS: Neonatal Infant Interventions to Prevent Asthma and Allergic Disease
Symposium 3: National Institute of Allergy and Infectious Disease (NIAID) and National Heart, Lung and Blood Institute (NHLBI): Standardizing Outcomes in Asthma Clinical Research
3-2CPS: Defining and Measuring Asthma Exacerbations
3-2CPS: Defining and Measuring Asthma Exacerbations
Symposium 3: Latin American Society of Allergy, Asthma and Immunology: Hot Topics in Latin America
3-2SSS: Frequent Co-morbid Conditions with Asthma
3-2SSS: Frequent Co-morbid Conditions with Asthma
Symposium 3: Henry Ford Hospital, Georgia Health Sciences University, the University of California San Francisco and The University of Michigan: Allergy Prevention: Do Cats and Dogs Feed Infants Microbes?
3-2UTP: Molecular Analysis of the Link Between Pets and an Infant's Microbiome
3-2UTP: Molecular Analysis of the Link Between Pets and an Infant's Microbiome
Workshop 3: Update on Vaccinations for the Allergist and Immunologist
3-2WS: Geriatric Considerations
3-2WS: Geriatric Considerations
Symposium 3: National Institute of Allergy and Infectious Disease (NIAID) and National Heart, Lung and Blood Institute (NHLBI): Standardizing Outcomes in Asthma Clinical Research
3-3CPS: Defining and Measuring Asthma Symptoms
3-3CPS: Defining and Measuring Asthma Symptoms
Symposium 3: Henry Ford Hospital, Georgia Health Sciences University, the University of California San Francisco and The University of Michigan: Allergy Prevention: Do Cats and Dogs Feed Infants Microbes?
3-3UTP: The Microbiome-Allergy Hypothesis
3-3UTP: The Microbiome-Allergy Hypothesis
Symposium 3: National Institute of Allergy and Infectious Disease (NIAID) and National Heart, Lung and Blood Institute (NHLBI): Standardizing Outcomes in Asthma Clinical Research
3-4CPS: Defining and Measuring Asthma Control
3-4CPS: Defining and Measuring Asthma Control
New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 2
3-4NH: Systems Biology Applications for Allergy and Asthma
3-4NH: Systems Biology Applications for Allergy and Asthma
New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 2
3-5NH: Nanomedicine Applications for Allergy and Vaccines
3-5NH: Nanomedicine Applications for Allergy and Vaccines
New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 2
3-6NH: Genetics and Genomics for Severe Asthma and COPD
3-6NH: Genetics and Genomics for Severe Asthma and COPD
Breakfast Symposium 4: Biology of Aeroallergens in Latin America
4-1BS: Biology of Aeroallergens in Latin America
4-1BS: Biology of Aeroallergens in Latin America
Symposium 4: American Lung Association - Asthma Clinical Research Network: Asthma in the Elderly (AIE): Challenges and Opportunities
4-1CPS: Diagnostic and Management Challenges
4-1CPS: Diagnostic and Management Challenges
New Horizons Session 4: Drug Allergy: New Insights in Drug Hypersensitivity
4-1NH: Immunogenetics of Severe Drug Hypersensitivity
4-1NH: Immunogenetics of Severe Drug Hypersensitivity
Breakfast Symposium 4: Biology of Aeroallergens in Latin America
4-2BS: Biology of Aeroallergens in Latin America
4-2BS: Biology of Aeroallergens in Latin America
Symposium 4: American Lung Association - Asthma Clinical Research Network: Asthma in the Elderly (AIE): Challenges and Opportunities
4-2CPS: Atopy and Aging: An Ongoing Challenge
4-2CPS: Atopy and Aging: An Ongoing Challenge
New Horizons Session 4: Drug Allergy: New Insights in Drug Hypersensitivity
4-2NH: Virus Infections and Drug Hypersensitivity
4-2NH: Virus Infections and Drug Hypersensitivity
Symposium 4: Brazilian Society of Allergy and Immunopathology: Debate: Allergy and Breast Feeding
4-2SSS: Con
4-2SSS: Con
Symposium 4: American Lung Association - Asthma Clinical Research Network: Asthma in the Elderly (AIE): Challenges and Opportunities
4-3CPS: Immunologic Changes in Aging
4-3CPS: Immunologic Changes in Aging
New Horizons Session 4: Drug Allergy: New Insights in Drug Hypersensitivity
4-3NH: In-Vitro Diagnosis of Drug Allergy: Current Status and Perspectives
4-3NH: In-Vitro Diagnosis of Drug Allergy: Current Status and Perspectives
New Horizons Session 4: Drug Allergy: Management of Drug Hypersensitivity
4-4NH: Beta-Lactam Allergy Diagnosis and Management
4-4NH: Beta-Lactam Allergy Diagnosis and Management
New Horizons Session 4: Drug Allergy: Management of Drug Hypersensitivity
4-5NH: Intra-Operative Reactions
4-5NH: Intra-Operative Reactions
Symposium 5: National Heart, Lung and Blood Institute (NHLBI) Clinical Research Network’s New Findings on the Stepwise Approach to Managing Asthma
5-1CPS: Step Up Therapy in Children
5-1CPS: Step Up Therapy in Children
New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 1
5-1NH: Overview of Co-Morbid Conditions
5-1NH: Overview of Co-Morbid Conditions
Symposium 5: INTERASMA: Control and Prevention of Asthma Exacerbation
5-3SSS: Asthma Evolution from Childhood to Adulthood
5-3SSS: Asthma Evolution from Childhood to Adulthood
New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 2
5-4NH: Vitamin D, Obesity and Asthma
5-4NH: Vitamin D, Obesity and Asthma
Breakfast Symposium 6: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
6-1BS: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
6-1BS: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
Symposium 6: Insights from the Global Allergy and Asthma Network (GA²LEN)
6-1CPS: Can the Severity of Allergy be Uniformly Defined?
6-1CPS: Can the Severity of Allergy be Uniformly Defined?
New Horizons Session 6: Advances in Food Allergy: Session 1
6-1NH: Allergen Component and Cross Reactivity
6-1NH: Allergen Component and Cross Reactivity
Symposium 6: American College of Allergy, Asthma and Immunology: When Food Allergies are Unusual, Unexpected, and Potentially Fatal
6-1SSS: Atypical Manifestations
6-1SSS: Atypical Manifestations
Symposium 6: Obstructive Sleep Apnea (OSA) Syndrome and Allergic Respiratory Diseases
6-1SY: Upper Airway Diseases
6-1SY: Upper Airway Diseases
Workshop 6: University Training Program - University of Sao Paulo: Allergy and Asthma: Risk Factors, Diagnosis and Treatment
6-1WS: Risk Factors for Allergy and Asthma in Latin America
6-1WS: Risk Factors for Allergy and Asthma in Latin America
Breakfast Symposium 6: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
6-2BS: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
6-2BS: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma
Symposium 6: Insights from the Global Allergy and Asthma Network (GA²LEN)
6-2CPS: GA²LEN in Europe and Beyond
6-2CPS: GA²LEN in Europe and Beyond
Symposium 6: American College of Allergy, Asthma and Immunology: When Food Allergies are Unusual, Unexpected, and Potentially Fatal
6-2SSS: Non-Ingestant Routes
6-2SSS: Non-Ingestant Routes
Workshop 6: University Training Program - University of Sao Paulo: Allergy and Asthma: Risk Factors, Diagnosis and Treatment
6-2WS: Cross-Reactive IgE Responses to Invertebrates
6-2WS: Cross-Reactive IgE Responses to Invertebrates
Symposium 6: Insights from the Global Allergy and Asthma Network (GA²LEN)
6-3CPS: GA²LEN, WAO and Guidelines
6-3CPS: GA²LEN, WAO and Guidelines
Symposium 6: American College of Allergy, Asthma and Immunology: When Food Allergies are Unusual, Unexpected, and Potentially Fatal
6-3SSS: Food-Induced Anaphylaxis: Diagnosis and Treatment
6-3SSS: Food-Induced Anaphylaxis: Diagnosis and Treatment
Symposium 6: Obstructive Sleep Apnea (OSA) Syndrome and Allergic Respiratory Diseases
6-3SY: Management
6-3SY: Management
New Horizons Session 6: Advances in Food Allergy: Session 2
6-5NH: Food Allergy and Eosinophilic Esophagitis
6-5NH: Food Allergy and Eosinophilic Esophagitis
New Horizons Session 6: Advances in Food Allergy: Session 2
6-6NH: Non-IgE-Mediated Gastrointestinal Food Reactions
6-6NH: Non-IgE-Mediated Gastrointestinal Food Reactions
Symposium 7: European Academy of Allergy and Clinical Immunology: Phenotypes and Endotypes of Allergic Disease
7-1SSS: Molecular Markers of Phenotypes and Endotypes
7-1SSS: Molecular Markers of Phenotypes and Endotypes
Workshop 7: Undergraduate and Postgraduate Training in Allergy: New Developments - WAO Specialty and Training Council
7-1WS: Allergy Education and Training: The WAO White Book on Allergy
7-1WS: Allergy Education and Training: The WAO White Book on Allergy
Symposium 7: Atopic Eczema: Barrier Dysfunction or Immune Deviation?
7-2DB: Barrier Dysfunction in Atopic Eczema is Crucial
7-2DB: Barrier Dysfunction in Atopic Eczema is Crucial
Plenary Session 7: Microbiome: A New Window to Health and Allergic Diseases?
7-2PS: Atopic Dermatitis
7-2PS: Atopic Dermatitis
Workshop 7: Undergraduate and Postgraduate Training in Allergy: New Developments - WAO Specialty and Training Council
7-2WS: WAO Guidelines on Undergraduate Allergy Education and Training
7-2WS: WAO Guidelines on Undergraduate Allergy Education and Training
Breakfast Symposium 8: What to Do with a Patient that Cannot Smell?
8-1BS: What to Do with a Patient that Cannot Smell?
8-1BS: What to Do with a Patient that Cannot Smell?
Symposium 8: German Society for Allergology and Clinical Immunology: Microbes - Friends or Foes of Allergic Disease?
8-1SSS: Role of Skin-Colonizing Microbes in Atopic Dermatitis
8-1SSS: Role of Skin-Colonizing Microbes in Atopic Dermatitis
Breakfast Symposium 8: What to Do with a Patient that Cannot Smell?
8-2BS: What to Do with a Patient that Cannot Smell?
8-2BS: What to Do with a Patient that Cannot Smell?
Symposium 8: German Society for Allergology and Clinical Immunology: Microbes - Friends or Foes of Allergic Disease?
8-2SSS: From Staphylococcus Aureus Enterotoxins to Nasal Polyps and Asthma
8-2SSS: From Staphylococcus Aureus Enterotoxins to Nasal Polyps and Asthma
New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 1
8-3NH: Approach to the Patient with Recurrent Infections
8-3NH: Approach to the Patient with Recurrent Infections
Symposium 8: German Society for Allergology and Clinical Immunology: Microbes - Friends or Foes of Allergic Disease?
8-3SSS: The Role of Microbes in Allergy Protection
8-3SSS: The Role of Microbes in Allergy Protection
New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 2
8-6NH: Susceptibility to Infections
8-6NH: Susceptibility to Infections
Breakfast Symposium 9: Case Discussion on Patients with Possible Immune Deficiencies
9-1BS: Case Discussion on Patients with Possible Immune Deficiencies
9-1BS: Case Discussion on Patients with Possible Immune Deficiencies
Symposium 9: Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology: Food Allergy
9-1SSS: WAO Position Paper: Diagnosis and Rational for Action Against Cows Milk Allergy (DRACMA)
9-1SSS: WAO Position Paper: Diagnosis and Rational for Action Against Cows Milk Allergy (DRACMA)
Breakfast Symposium 9: Case Discussion on Patients with Possible Immune Deficiencies
9-2BS: Case Discussion on Patients with Possible Immune Deficiencies
9-2BS: Case Discussion on Patients with Possible Immune Deficiencies
Symposium 9: Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology: Food Allergy
9-2SSS: Risk Factors for Food Allergy for the Latin American Population
9-2SSS: Risk Factors for Food Allergy for the Latin American Population
Symposium 9: Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology: Food Allergy
9-3SSS: Food Hypersensitivity and Atopic Dermatitis in Toddlers
9-3SSS: Food Hypersensitivity and Atopic Dermatitis in Toddlers
Breakfast Symposium 10: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
10-1BS: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
10-1BS: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
Symposium 10: Allergy Society of South Africa: Aetiology of Allergy - Can Africa Help Provide the Answer?
10-1SSS: Linking Allergy and Asthma - Lessons from Africa
10-1SSS: Linking Allergy and Asthma - Lessons from Africa
Symposium 10: Genetic Respiratory Diseases and Their Association with Asthma
10-1SY: Alpha1 Antitrypsin
10-1SY: Alpha1 Antitrypsin
Breakfast Symposium 10: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
10-2BS: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
10-2BS: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)
Plenary Session 10: New Concepts in Mast Cell Mediators
10-2PS: Tryptase: From Anaphylaxis to Mastocytosis
10-2PS: Tryptase: From Anaphylaxis to Mastocytosis
Symposium 10: Allergy Society of South Africa: Aetiology of Allergy - Can Africa Help Provide the Answer?
10-2SSS: Food Allergy in South Africa: Increasing Prevalence
10-2SSS: Food Allergy in South Africa: Increasing Prevalence
Plenary Session 10: New Concepts in Mast Cell Mediators
10-3PS: Prostaglandin D2 (PGD2): Therapeutic Implications
10-3PS: Prostaglandin D2 (PGD2): Therapeutic Implications
Symposium 10: Genetic Respiratory Diseases and Their Association with Asthma
10-3SY: Cystic Fibrosis
10-3SY: Cystic Fibrosis
Symposium 11: Korean Academy of Allergy, Asthma and Clinical Immunology: Severe Asthma
11-1SSS: Clinical Features of Severe Asthma: Korean Cohort Study
11-1SSS: Clinical Features of Severe Asthma: Korean Cohort Study
Breakfast Symposium 11: Inflammasomes and Allergic Diseases
11-2BS: Inflammasomes and Allergic Diseases
11-2BS: Inflammasomes and Allergic Diseases
Symposium 11: Korean Academy of Allergy, Asthma and Clinical Immunology: Severe Asthma
11-3SSS: Management of Severe Asthma
11-3SSS: Management of Severe Asthma
Breakfast Symposium 12: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
12-1BS: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
12-1BS: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
Symposium 12: Southern European Allergy Societies (SEAS): Immunotherapy
12-1SSS: Safety and Efficacy with Polimerized Extracts
12-1SSS: Safety and Efficacy with Polimerized Extracts
Symposium 12: Eosinophilic Respiratory Problems
12-1SY: Aspirin-Exacerbated Respiratory Disease (AERD)
12-1SY: Aspirin-Exacerbated Respiratory Disease (AERD)
Breakfast Symposium 12: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
12-2BS: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
12-2BS: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children
Symposium 12: Southern European Allergy Societies (SEAS): Immunotherapy
12-2SSS: Omalizumab Plus Immunotherapy
12-2SSS: Omalizumab Plus Immunotherapy
Symposium 12: Eosinophilic Respiratory Problems
12-3SY: Allergic Bronchopulmonary Aspergillosis (ABPA)
12-3SY: Allergic Bronchopulmonary Aspergillosis (ABPA)
Symposium 13: Venezuelan Society of Allergy and Immunology: Genetic and Epigenetic Implications in Allergic and Asthmatic Latin Americans
13-1SSS: Genetics
13-1SSS: Genetics
Breakfast Symposium 13: Practical Considerations for Prescribing Sublingual Immunotherapy (SLIT)
13-2BS: Practical Considerations for Prescribing Sublingual Immunotherapy (SLIT)
13-2BS: Practical Considerations for Prescribing Sublingual Immunotherapy (SLIT)
Symposium 13: Venezuelan Society of Allergy and Immunology: Genetic and Epigenetic Implications in Allergic and Asthmatic Latin Americans
13-2SSS: Prescription Patterns
13-2SSS: Prescription Patterns
Workshop 13: Severe Cutaneous Drug Reactions
13-2WS: Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Syndrome
13-2WS: Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Syndrome
Workshop 13: Severe Cutaneous Drug Reactions
13-3WS: Toxic Epidermal Necrolysis (TEN) and Steven Johnson Syndrome
13-3WS: Toxic Epidermal Necrolysis (TEN) and Steven Johnson Syndrome
• TEN.ppt
Symposium 14: Mexican College of Clinical Immunology and Allergy: Genetics and Immune Responses
14-1SSS: Genetic Risk Factor for Asthma in Latin America
14-1SSS: Genetic Risk Factor for Asthma in Latin America
Symposium 14: Clinical Use of Probiotic Products for Allergy – A WAO Paper - WAO Special Committee on Food Allergy
14-1SY: Presentation of the WAO Paper
14-1SY: Presentation of the WAO Paper
Workshop 14: Advances in the Diagnosis and Management of Ocular Allergy
14-1WS: Pathophysiology of Conjunctival Inflammation
14-1WS: Pathophysiology of Conjunctival Inflammation
Symposium 14: Clinical Use of Probiotic Products for Allergy – A WAO Paper - WAO Special Committee on Food Allergy
14-2SY: The Microbiological Underpinnings
14-2SY: The Microbiological Underpinnings
Workshop 14: Advances in the Diagnosis and Management of Ocular Allergy
14-2WS: The Clinical Spectrum of Ocular Allergy
14-2WS: The Clinical Spectrum of Ocular Allergy
Symposium 14: Mexican College of Clinical Immunology and Allergy: Genetics and Immune Responses
14-3SSS: Immunogenetics and Pharmacogenomics of Allergic Diseases
14-3SSS: Immunogenetics and Pharmacogenomics of Allergic Diseases
Symposium 14: Clinical Use of Probiotic Products for Allergy – A WAO Paper - WAO Special Committee on Food Allergy
14-3SY: Probiotics and Allergic Diseases
14-3SY: Probiotics and Allergic Diseases
Workshop 14: Advances in the Diagnosis and Management of Ocular Allergy
14-3WS: Ocular Allergy Treatment
14-3WS: Ocular Allergy Treatment
Breakfast Symposium 15: University Training Program - Universidad Autonoma de Nuevo Leon: Insect Allergy
15-1BS: University Training Program - Universidad Autonoma de Nuevo Leon: Insect Allergy
15-1BS: University Training Program - Universidad Autonoma de Nuevo Leon: Insect Allergy
Symposium 15: The International Primary Care Respiratory Group: Rhinitis and Asthma in Primary Care
15-1SSS: Adaption of Asthma Guidelines to Primary Care
15-1SSS: Adaption of Asthma Guidelines to Primary Care
Breakfast Symposium 15: University Training Program - Universidad Autonoma de Nuevo Leon: Insect Allergy
15-2BS: Speaker
15-2BS: Speaker
Symposium 15: The International Primary Care Respiratory Group: Rhinitis and Asthma in Primary Care
15-2SSS: Sublingual Immunotherapy (SLIT) in Primary Care
15-2SSS: Sublingual Immunotherapy (SLIT) in Primary Care
Symposium 15: Patient Education and Treatment Compliance in Allergic Rhinitis - Supported through an unrestricted educational grant from Takeda
15-2SY: In Asia Pacific
15-2SY: In Asia Pacific
Symposium 15: The International Primary Care Respiratory Group: Rhinitis and Asthma in Primary Care
15-3SSS: Management of Rhinitis or Sinusitis in Primary Care Patients with Asthma
15-3SSS: Management of Rhinitis or Sinusitis in Primary Care Patients with Asthma
Symposium 15: Patient Education and Treatment Compliance in Allergic Rhinitis - Supported through an unrestricted educational grant from Takeda
15-3SY: In the United States
15-3SY: In the United States
Workshop 15: Contact Dermatitis in Children
15-3WS: Contact Dermatitis in Children: Do We Need Regular Patch Testing?
15-3WS: Contact Dermatitis in Children: Do We Need Regular Patch Testing?
Symposium 15: Patient Education and Treatment Compliance in Allergic Rhinitis - Supported through an unrestricted educational grant from Takeda
15-4SY: In Latin America
15-4SY: In Latin America
Symposium 16: Argentine Association of Allergy and Clinical Immunology: Eosinophilic Related Conditions
16-1SSS: Evaluation of Patients with Eosinophilia
16-1SSS: Evaluation of Patients with Eosinophilia
Workshop 16: Obstructive Sleep Disorders in Breathing in Childhood
16-1WS: School and Behavior Problems
16-1WS: School and Behavior Problems
Breakfast Symposium 16: Treatment of the Asthmatic Patient Under Age 5
16-2BS: Treatment of the Asthmatic Patient Under Age 5
16-2BS: Treatment of the Asthmatic Patient Under Age 5
Symposium 16: Argentine Association of Allergy and Clinical Immunology: Eosinophilic Related Conditions
16-2SSS: Hypereosinophilic Syndromes
16-2SSS: Hypereosinophilic Syndromes
Breakfast Symposium 16: Treatment of the Asthmatic Patient Under Age 5
16-3BS: Treatment of the Asthmatic Patient Under Age 5
16-3BS: Treatment of the Asthmatic Patient Under Age 5
Symposium 16: Argentine Association of Allergy and Clinical Immunology: Eosinophilic Related Conditions
16-3SSS: Novel Therapies for Eosinophilic Disorders
16-3SSS: Novel Therapies for Eosinophilic Disorders
Workshop 16: Obstructive Sleep Disorders in Breathing in Childhood
16-3WS: Adenotonsillar Hypertrophy
16-3WS: Adenotonsillar Hypertrophy
Breakfast Symposium 17: Evaluation of Patients for Antibody Deficiency
17-1BS: Evaluation of Patients for Antibody Deficiency
17-1BS: Evaluation of Patients for Antibody Deficiency
Workshop 17: The Use of Forms and Templates in Office Practice
17-1WS: History, Physical Examination and Skin Testing
17-1WS: History, Physical Examination and Skin Testing
Breakfast Symposium 18: Exercise-Induced Asthma and Allergic Conditions
18-1BS: Exercise-Induced Asthma and Allergic Conditions
18-1BS: Exercise-Induced Asthma and Allergic Conditions
Symposium 18: Hereditary Angioedema (HAE) and the WAO Consensus Document - WAO HAE International Alliance
18-1SY: Summary of the WAO Document
18-1SY: Summary of the WAO Document
Workshop 18: University Training Program - University of South Florida: Hands-On Session: Rhinolaryngoscopy (Session #2)
18-1WS: University Training Program - University of South Florida: Rhinolaryngoscopy: Hands-On (Session #2)
18-1WS: University Training Program - University of South Florida: Rhinolaryngoscopy: Hands-On (Session #2)
Breakfast Symposium 18: Exercise-Induced Asthma and Allergic Conditions
18-2BS: Exercise-Induced Asthma and Allergic Conditions
18-2BS: Exercise-Induced Asthma and Allergic Conditions
Symposium 18: Hereditary Angioedema (HAE) and the WAO Consensus Document - WAO HAE International Alliance
18-2SY: Pathogenesis
18-2SY: Pathogenesis
Symposium 18: Hereditary Angioedema (HAE) and the WAO Consensus Document - WAO HAE International Alliance
18-3SY: Clinical Presentation
18-3SY: Clinical Presentation
Symposium 18: Hereditary Angioedema (HAE) and the WAO Consensus Document - WAO HAE International Alliance
18-4SY: New Approaches to Treatment
18-4SY: New Approaches to Treatment
Breakfast Symposium 19: Pharmacotherapy for the Geriatric Asthma Patient
19-1BS: Pharmacotherapy for the Geriatric Asthma Patient
19-1BS: Pharmacotherapy for the Geriatric Asthma Patient
Symposium 19: Air Pollution and Climate Change and Their Effects on Allergic Respiratory Diseases - WAO Special Committee on Climate Change
19-1SY: Air Pollution, Climate Change and Extreme Events Leading to Asthma Exacerbations
19-1SY: Air Pollution, Climate Change and Extreme Events Leading to Asthma Exacerbations
Symposium 19: Air Pollution and Climate Change and Their Effects on Allergic Respiratory Diseases - WAO Special Committee on Climate Change
19-2SY: Air Pollution, Climate Change and Hygiene Hypothesis
19-2SY: Air Pollution, Climate Change and Hygiene Hypothesis
Workshop 19: Controversies Surrounding Long-Acting Beta Agonists (LABAs) in Asthma
19-2WS: Step-Down Therapy
19-2WS: Step-Down Therapy
Workshop 19: Controversies Surrounding Long-Acting Beta Agonists (LABAs) in Asthma
19-3WS: Step-Up Therapy
19-3WS: Step-Up Therapy
Workshop 20: Decreasing the Prevalence of Allergic Diseases and Asthma - The WAO World Allergy Action Plan
20-2WS: Allergy Health in Children
20-2WS: Allergy Health in Children
Workshop 20: Decreasing the Prevalence of Allergic Diseases and Asthma - The WAO World Allergy Action Plan
20-3WS: Allergy as an Immune Adaptation Syndrome
20-3WS: Allergy as an Immune Adaptation Syndrome
Breakfast Symposium 21: Diagnosis and Management of Anaphylaxis
21-2BS: Diagnosis and Management of Anaphylaxis
21-2BS: Diagnosis and Management of Anaphylaxis
Workshop 21: Diagnostic Procedures for Rhinitis
21-3WS: Clinical Considerations and Quality of Life: Implications for Treatment
21-3WS: Clinical Considerations and Quality of Life: Implications for Treatment
Workshop 22: Immunotherapy for the Polysensitized Patient: Balancing the Evidence with Experience
22-1WS: Monotherapy for the Polysensitized Patient
22-1WS: Monotherapy for the Polysensitized Patient
Workshop 22: Immunotherapy for the Polysensitized Patient: Balancing the Evidence with Experience
22-2WS: Multiallergen Immunotherapy: The Evidence
22-2WS: Multiallergen Immunotherapy: The Evidence
Workshop 22: Immunotherapy for the Polysensitized Patient: Balancing the Evidence with Experience
22-3WS: Multiallergen Immunotherapy: The Experience
22-3WS: Multiallergen Immunotherapy: The Experience
Symposium 23: WAO Junior Members Group
23-1SY: How a Protein Becomes an Allergen and an Allergen a Candidate for Correct Diagnosis and/or Immunotherapy. Ole e 11 as a Model to Study
23-1SY: How a Protein Becomes an Allergen and an Allergen a Candidate for Correct Diagnosis and/or Immunotherapy. Ole e 11 as a Model to Study
Workshop 23: Austrian Society of Allergology and Immunology Sister Society Session: Novel Laboratory Tests for Allergic Diseases
23-1WS: Recombinant Allergens for Diagnosis
23-1WS: Recombinant Allergens for Diagnosis
Symposium 23: WAO Junior Members Group
23-3SY: Sensitization to Fungi and its Relation to Asthma and Allergic Rhinitis
23-3SY: Sensitization to Fungi and its Relation to Asthma and Allergic Rhinitis
Symposium 23: WAO Junior Members Group
23-4SY: Skin Irritation and Allergic Contact Sensitization in Atopic Dermatitis
23-4SY: Skin Irritation and Allergic Contact Sensitization in Atopic Dermatitis
Symposium 23: WAO Junior Members Group
23-5SY: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
23-5SY: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy
Workshop 24: University Training Program - Cleveland Clinic: An Evidence Based Approach to Diagnosis and Management of Urticaria and Angioedema
24-1WS: Evaluation
24-1WS: Evaluation
Symposium 24: Why are Small Airways Important in Asthma? - This WAO Symposium is supported through unrestricted educational grants from Teva and Takeda
24-2SY: Physiology of Small Airways Disease
24-2SY: Physiology of Small Airways Disease
Workshop 24: University Training Program - Cleveland Clinic: An Evidence Based Approach to Diagnosis and Management of Urticaria and Angioedema
24-2WS: Management
24-2WS: Management
Symposium 24: Why are Small Airways Important in Asthma? - This WAO Symposium is supported through unrestricted educational grants from Teva and Takeda
24-3SY: Particle Deposition and Pharmacotherapy of Small Airways Disease
24-3SY: Particle Deposition and Pharmacotherapy of Small Airways Disease
Breakfast Symposium 26: Gastrointestinal (GI) Complaints in Food Allergy
26-1BS: Gastrointestinal (GI) Complaints in Food Allergy
26-1BS: Gastrointestinal (GI) Complaints in Food Allergy
Workshop 26: Obesity and Asthma: Implications for Asthma Control and Treatment
26-1WS: Observational Studies
26-1WS: Observational Studies
Workshop 26: Obesity and Asthma: Implications for Asthma Control and Treatment
26-3WS: Genetics of Obesity and Asthma
26-3WS: Genetics of Obesity and Asthma
Breakfast Symposium 27: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
27-1BS: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
27-1BS: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
Symposium 27: 2013 EAACI-WAO World Allergy & Asthma Congress - Milan, Italy: Novel and Emerging Therapeutic Strategies for Allergy and Asthma
27-1SY: Immunomodulators - A Brave New World
27-1SY: Immunomodulators - A Brave New World
Breakfast Symposium 27: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
27-2BS: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
27-2BS: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response
Symposium 27: 2013 EAACI-WAO World Allergy & Asthma Congress - Milan, Italy: Novel and Emerging Therapeutic Strategies for Allergy and Asthma
27-2SY: Inducing Immune Tolerance to Allergens - Implications for Treatment
27-2SY: Inducing Immune Tolerance to Allergens - Implications for Treatment
Workshop 27: Update on Smoking Cessation
27-3WS: Clinical Trials and Patient Education for Smoking Cessation
27-3WS: Clinical Trials and Patient Education for Smoking Cessation
Symposium 28: Immunobiologic Approaches in Allergy
28-1SY: Translational Research and Immunomodulators in Allergy
28-1SY: Translational Research and Immunomodulators in Allergy
Workshop 28: Allergic Rhinitis and Its Impact on Asthma (ARIA)
28-2WS: Are Rhinitis and Asthma Two Manifestations of One Disease?
28-2WS: Are Rhinitis and Asthma Two Manifestations of One Disease?
Workshop 28: Allergic Rhinitis and Its Impact on Asthma (ARIA)
28-3WS: Rhinitis: A Risk Factor for Asthma?
28-3WS: Rhinitis: A Risk Factor for Asthma?
Symposium 29: Primary Immune Deficiencies: Rapid Diagnosis and Referral
29-1SY: Clinical Presentation
29-1SY: Clinical Presentation
Workshop 29: Adherence to Treatment: How Can It Be Improved?
29-2WS: Socio-economic Status and Adherence
29-2WS: Socio-economic Status and Adherence
Breakfast Symposium 31: Choosing a Career Path in Allergy and Immunology
31-1BS: Choosing a Career Path in Allergy and Immunology
31-1BS: Choosing a Career Path in Allergy and Immunology
Breakfast Symposium 31: Choosing a Career Path in Allergy and Immunology
31-2BS: Choosing a Career Path in Allergy and Immunology
31-2BS: Choosing a Career Path in Allergy and Immunology
Symposium 31: Hymenoptera Allergy: Ants and Flying Insects
31-3SY: Immunologic Response with Venom Immunotherapy
31-3SY: Immunologic Response with Venom Immunotherapy
Breakfast Symposium 33: Complementary and Alternative Medicine: Does it Work?
33-1BS: Complementary and Alternative Medicine: Does it Work?
33-1BS: Complementary and Alternative Medicine: Does it Work?
Breakfast Symposium 33: Complementary and Alternative Medicine: Does it Work?
33-3BS: Complementary and Alternative Medicine: Does it Work?
33-3BS: Complementary and Alternative Medicine: Does it Work?